Effects of K11R and G31P Mutations on the Structure and Biological Activities of CXCL8: Solution Structure of Human CXCL8K11R/G31P

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2017 Jul 30

PMID 28754019

Citations 3

Authors

Hsi-Tsung Cheng

Hui-Yuan Yu

John R Gordon

Fang Li

Jya-Wei Cheng

Affiliations

Soon will be listed here.

Abstract

The ELR-CXC chemokines are important to neutrophil inflammation in many acute and chronic diseases. Among them, CXCL8 (interleukin-8, IL-8), the expression levels of which are elevated in many inflammatory diseases, binds to both the CXCR1 and CXCR2 receptors with high affinity. Recently, an analogue of human CXCL8, CXCL8K11R/G31P (hG31P) has been developed. It has been demonstrated that hG31P is a high affinity antagonist for both the CXCR1 and CXCR2. Herein, we have determined the solution structure and the CXCR1 N-terminal peptide binding sites of hG31P by NMR spectroscopy. We have found that the displacement within the tertiary structure of the 30 s loop and the N-terminal region and more specifically change of the loop conformation (especially H33), of hG31P may affect its binding to the CXCR1 receptor and thereby inhibit human neutrophil chemotactic responses induced by ELR-CXC chemokines. Our results provide a structural basis for future clinical investigations of this CXCR1/CXCR2 receptor antagonist and for the further development of CXCL8 based antagonists.

Citing Articles

Exploring the mechanism of action of licorice in the treatment of COVID-19 through bioinformatics analysis and molecular dynamics simulation.

Cao J, Gong Y, Wu M, Yang X, Xiong L, Chen S Front Pharmacol. 2022; 13:1003310.

PMID: 36120307 PMC: 9481297. DOI: 10.3389/fphar.2022.1003310.

Porcine CXCR1/2 antagonist CXCL8G31P inhibits lung inflammation in LPS-challenged mice.

Wang X, Li Y, Li L, Jiao Z, Liu X, Cheng G Sci Rep. 2020; 10(1):1210.

PMID: 31988368 PMC: 6985246. DOI: 10.1038/s41598-020-57737-w.

A novel CXCL8 analog is effective in inhibiting the growth via cell cycle arrest and attenuating invasion of Lewis lung carcinoma.

Hsu S, Yu H, Lee W, Hsiao C, Wu C, Cheng H Onco Targets Ther. 2019; 12:7611-7621.

PMID: 31571912 PMC: 6754332. DOI: 10.2147/OTT.S215824.

References

Wishart D, Bigam C, Yao J, Abildgaard F, Dyson H, Oldfield E . 1H, 13C and 15N chemical shift referencing in biomolecular NMR. J Biomol NMR. 1995; 6(2):135-40. DOI: 10.1007/BF00211777. View

Cornilescu G, Delaglio F, Bax A . Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J Biomol NMR. 1999; 13(3):289-302. DOI: 10.1023/a:1008392405740. View

Zhao X, Town J, Li F, Zhang X, Cockcroft D, Gordon J . ELR-CXC chemokine receptor antagonism targets inflammatory responses at multiple levels. J Immunol. 2009; 182(5):3213-22. DOI: 10.4049/jimmunol.0800551. View

Zhao X, Town J, Li F, Li W, Zhang X, Gordon J . Blockade of neutrophil responses in aspiration pneumonia via ELR-CXC chemokine antagonism does not predispose to airway bacterial outgrowth. Pulm Pharmacol Ther. 2009; 23(1):22-8. DOI: 10.1016/j.pupt.2009.09.001. View

Allen S, Crown S, Handel T . Chemokine: receptor structure, interactions, and antagonism. Annu Rev Immunol. 2007; 25:787-820. DOI: 10.1146/annurev.immunol.24.021605.090529. View

Markley J, Bax A, Arata Y, Hilbers C, Kaptein R, Sykes B . Recommendations for the presentation of NMR structures of proteins and nucleic acids. IUPAC-IUBMB-IUPAB Inter-Union Task Group on the Standardization of Data Bases of Protein and Nucleic Acid Structures Determined by NMR Spectroscopy. J Biomol NMR. 1998; 12(1):1-23. DOI: 10.1023/a:1008290618449. View

Bizzarri C, Beccari A, Bertini R, Cavicchia M, Giorgini S, Allegretti M . ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets. Pharmacol Ther. 2006; 112(1):139-49. DOI: 10.1016/j.pharmthera.2006.04.002. View

Koradi R, Billeter M, Wuthrich K . MOLMOL: a program for display and analysis of macromolecular structures. J Mol Graph. 1996; 14(1):51-5, 29-32. DOI: 10.1016/0263-7855(96)00009-4. View

Campbell L, Maxwell P, Waugh D . Rationale and Means to Target Pro-Inflammatory Interleukin-8 (CXCL8) Signaling in Cancer. Pharmaceuticals (Basel). 2013; 6(8):929-59. PMC: 3817732. DOI: 10.3390/ph6080929. View

10.

Li F, Gordon J . Il-8((3-73))K11R is a high affinity agonist of the neutrophil CXCR1 and CXCR2. Biochem Biophys Res Commun. 2001; 286(3):595-600. DOI: 10.1006/bbrc.2001.5423. View

11.

Clark-Lewis I, DEWALD B, Loetscher M, Moser B, Baggiolini M . Structural requirements for interleukin-8 function identified by design of analogs and CXC chemokine hybrids. J Biol Chem. 1994; 269(23):16075-81. View

12.

Hebert C, Vitangcol R, Baker J . Scanning mutagenesis of interleukin-8 identifies a cluster of residues required for receptor binding. J Biol Chem. 1991; 266(28):18989-94. View

13.

Cheng H, Huang K, Yu H, Gao K, Zhao X, Li F . A new protocol for high-yield purification of recombinant human CXCL8((3-72))K11R/G31P expressed in Escherichia coli. Protein Expr Purif. 2008; 61(1):65-72. DOI: 10.1016/j.pep.2008.04.007. View

14.

Rajagopalan L, Rajarathnam K . Structural basis of chemokine receptor function--a model for binding affinity and ligand selectivity. Biosci Rep. 2006; 26(5):325-39. PMC: 2671010. DOI: 10.1007/s10540-006-9025-9. View

15.

Mayer M, Meyer B . Characterization of Ligand Binding by Saturation Transfer Difference NMR Spectroscopy. Angew Chem Int Ed Engl. 2018; 38(12):1784-1788. DOI: 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q. View

16.

Zhao X, Town J, Yang A, Zhang X, Paur N, Sawicki G . A novel ELR-CXC chemokine antagonist reduces intestinal ischemia reperfusion-induced mortality, and local and remote organ injury. J Surg Res. 2009; 162(2):264-73. DOI: 10.1016/j.jss.2009.04.047. View

17.

Hammond M, Shyamala V, Siani M, Gallegos C, Feucht P, Abbott J . Receptor recognition and specificity of interleukin-8 is determined by residues that cluster near a surface-accessible hydrophobic pocket. J Biol Chem. 1996; 271(14):8228-35. DOI: 10.1074/jbc.271.14.8228. View

18.

Ferentz A, Wagner G . NMR spectroscopy: a multifaceted approach to macromolecular structure. Q Rev Biophys. 2000; 33(1):29-65. DOI: 10.1017/s0033583500003589. View

19.

Baldwin E, Weber I, St Charles R, Xuan J, Appella E, Yamada M . Crystal structure of interleukin 8: symbiosis of NMR and crystallography. Proc Natl Acad Sci U S A. 1991; 88(2):502-6. PMC: 50839. DOI: 10.1073/pnas.88.2.502. View

20.

Laskowski R, Rullmannn J, MacArthur M, Kaptein R, Thornton J . AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR. 1996; 8(4):477-86. DOI: 10.1007/BF00228148. View